flucytosine has been researched along with Esophagitis in 5 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
Esophagitis: INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study has been to evaluate the role, therapeutic efficacy, and the cost-benefit ratio of two antifungal drugs, fluconazole and flucytosine, compared with a placebo, in the treatment of endoscopically-diagnosed esophageal candidiasis in patients with acquired immune deficiency syndrome (AIDS)." | 9.08 | Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "To assess the role and the therapeutic efficacy of fluconazole and itraconazole-flucytosine association compared with placebo, in the treatment of endoscopically diagnosed esophageal candidiasis in a selected population of AIDS patients." | 9.08 | Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1996) |
| " The aim of this study has been to evaluate the role, therapeutic efficacy, and the cost-benefit ratio of two antifungal drugs, fluconazole and flucytosine, compared with a placebo, in the treatment of endoscopically-diagnosed esophageal candidiasis in patients with acquired immune deficiency syndrome (AIDS)." | 5.08 | Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1995) |
| "To assess the role and the therapeutic efficacy of fluconazole and itraconazole-flucytosine association compared with placebo, in the treatment of endoscopically diagnosed esophageal candidiasis in a selected population of AIDS patients." | 5.08 | Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group. ( Barbarini, G; Barbaro, G; Di Lorenzo, G, 1996) |
| "We performed antifungal susceptibility tests with cilofungin (LY121019), amphotericin B, and flucytosine against 38 strains of yeasts from patients with esophagitis or fungemia either before, during, or after treatment with cilofungin." | 3.69 | Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species. ( Cook, RA; Crane, LR; Galgiani, JN; Gallis, HA; Pappas, PG; Pottage, JC; Villareal, KM; Wenzel, RP, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbaro, G | 2 |
| Barbarini, G | 2 |
| Di Lorenzo, G | 2 |
| Villareal, KM | 1 |
| Cook, RA | 1 |
| Galgiani, JN | 1 |
| Wenzel, RP | 1 |
| Pappas, PG | 1 |
| Pottage, JC | 1 |
| Gallis, HA | 1 |
| Crane, LR | 1 |
| Kodsi, BE | 1 |
| Wickremesinghe, C | 1 |
| Kozinn, PJ | 1 |
| Iswara, K | 1 |
| Goldberg, PK | 1 |
| Brockmeyer, NH | 1 |
| Hantschke, D | 1 |
| Olbricht, T | 1 |
| Hengge, UA | 1 |
| Goos, M | 1 |
2 trials available for flucytosine and Esophagitis
| Article | Year |
|---|---|
Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1995 |
Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; | 1996 |
3 other studies available for flucytosine and Esophagitis
| Article | Year |
|---|---|
Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species.
Topics: Amphotericin B; Candida; Candidiasis; Drug Resistance, Microbial; Echinocandins; Esophagitis; Evalua | 1994 |
Candida esophagitis: a prospective study of 27 cases.
Topics: Adolescent; Adult; Aged; Candidiasis; Drug Therapy, Combination; Esophagitis; Esophagoscopy; Female; | 1976 |
[Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Esophagitis; Female; Fluconazole; Flucytosin | 1991 |